Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180073 | SCV000232438 | benign | not specified | 2015-02-11 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000755283 | SCV000603983 | benign | not provided | 2023-10-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000755283 | SCV001099379 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000986273 | SCV001135212 | likely benign | Schwartz-Jampel syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000986273 | SCV001252590 | benign | Schwartz-Jampel syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001096388 | SCV001252591 | benign | Lethal Kniest-like syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Athena Diagnostics | RCV000180073 | SCV001477269 | benign | not specified | 2019-11-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000755283 | SCV001897465 | benign | not provided | 2018-10-29 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277426 | SCV002566710 | likely benign | Connective tissue disorder | 2020-11-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500515 | SCV002795741 | likely benign | Lethal Kniest-like syndrome; Schwartz-Jampel syndrome type 1 | 2021-12-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000755283 | SCV004123427 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | HSPG2: BS2 |
Breakthrough Genomics, |
RCV000755283 | SCV005261803 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000755283 | SCV001799609 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000180073 | SCV001974796 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537500 | SCV004742190 | benign | HSPG2-related disorder | 2019-03-01 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |